Mark C. Schneyer, EVP, CFO: Acadia Pharmaceuticals ACAD Planned sale · Filed 25/08/18

Trade details

Type: Planned sale notice
Stock: Acadia Pharmaceuticals ACAD
Person: Mark C. SchneyerEVP, CFO
Planned sale date: 25/08/18
Filed: 25/08/18

$557.3K to be sold

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/07/19~25/09/17

Mark C. Schneyer's recent trades

Mark C. SchneyerEVP, CFO
Planned sale10b5-1 planAcadia Pharmaceuticals
Planned sale10b5-1 plan
Acadia Pharmaceuticals
ACAD
$158.8K
5,849 sh
$158.8K
Filed 08/05
Traded 08/05
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$76.4K
3,506 sh
$76.4K
Filed 05/05
Traded 05/04
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$60.1K
2,709 sh
$60.1K
Filed 04/07
Traded 04/07
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$89.7K
4,177 sh
$89.7K
Filed 03/26
Traded 03/25
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$68.7K
3,171 sh
$68.7K
Filed 03/26
Traded 03/26

Mark C. Schneyer, CFO — plans to sell 22,000 sh of Acadia Pharmaceuticals ACAD · $557.3K · around 08/18 · 10b5-1 plan | Whalegun